Literature DB >> 15164973

Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.

Brendan W Mason1, Anthony J Howard.   

Abstract

Resistance to fusidic acid among community methicillin susceptible Staphylococcus aureus (MSSA) isolates in the United Kingdom and prescriptions for fusidic acid have both doubled over the past 6 years. A retrospective case-control study was undertaken to test the hypothesis that the use of topical fusidic acid is associated with the isolation of resistant organisms. A statistically significant association was found between fusidic acid resistance in MSSA isolates and exposure to topical fusidic acid (odds ratio: 2.77, 95% CI 1.01-7.93, P = 0.027). This study demonstrates for the first time an association between the use of topical fusidic acid and resistance at the individual patient level and supports the hypothesis that the observed increase in resistance is causally associated with the increased use of topical fusidic acid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164973     DOI: 10.1016/j.ijantimicag.2003.09.013

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  9 in total

1.  Treatment for impetigo.

Authors:  Sander Koning; Johannes C van der Wouden
Journal:  BMJ       Date:  2004-09-25

2.  Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.

Authors:  Urs A Ochsner; Casey L Young; Kimberley C Stone; Frank B Dean; Nebojsa Janjic; Ian A Critchley
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Elisabeth Kugelberg; Tobias Norström; Thomas K Petersen; Tore Duvold; Dan I Andersson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Absence of bacterial resistance to medical-grade manuka honey.

Authors:  R A Cooper; L Jenkins; A F M Henriques; R S Duggan; N F Burton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-13       Impact factor: 3.267

Review 5.  Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

Authors:  Prabhavathi Fernandes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

6.  Retrospective Clinical Trial of Fusidic Acid versus Petrolatum in the Postprocedure Care of Clean Dermatologic Procedures.

Authors:  Dong Hun Lee; Dong Young Kim; So Young Yoon; Hyun Sun Park; Hyun-Sun Yoon; Soyun Cho
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

7.  Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.

Authors:  Tobias Norström; Jonas Lannergård; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

8.  Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus.

Authors:  M Al-Khulaifi Manal; M Amin Aref Nagwa; Ali A Al Salamah
Journal:  Saudi J Biol Sci       Date:  2009-07       Impact factor: 4.219

Review 9.  Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.